#20 Non-Invasive Neurostimulation for Sleep: Neurovalens CEO Jason McKeown

Free Neurotech Newsletter: https://neurotechnologynews.beehiiv.com/subscribe

Key Moments:

0:00 Introduction

3:23 Initial Interest in Neuroscience/Neurotechnology

5:10 Neurovalens: Background, Timeline, Origins

7:52 Clinical Trials: Insomnia, Anxiety, Obesity, PTSD, Diabetes 

8:40 Neurostimulation: Type and Target

10:40 Exploring Various Treatment Types with Neurovalens

17:29 Patient Experience

20:40 Target Nerves and Brain Regions

22:56 Competitors and Differentiators

25:32 What is next for Neurovalens?

27:34 Commercialization

29:55 Patient Education

30:39 Refund if it doesn’t work

31:53 Wellness Device - Big Learnings and Initial Sales

33:40 Early Adopters and Crowdfunding: Indiegogo

35:44 Real World Data and FDA Guidance

37:17 FDA Involvement in Wellness Space

40:23 FDA Confusion Launching Wellness Sleep Product

43:01 Advice for Breaking into Neurotech: Students/Young Professionals

45:14 The Future of Neurotech (20 years)

47:47 Community/Collaboration/Contact

Recorded: 2/8/2024

Host: Robert Murcko 

Neurovalens: https://neurovalens.com/